[1]. You WK, et al. VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res, 2011, 71(14), 4758-4768.
[2]. Torres KE, et al. Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors. Clin Cancer Res, 2011, 17(12), 3943-3955.
[3]. Yakes FM, et al. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol Cancer Ther, 2011, 10(12), 2298-2308.
1401791573(上海经销商,江苏,河南,湖北,内蒙古,新疆,西藏,香港,台湾)
3610331285(上海终端,浙江,湖南,重庆,安徽,甘肃,山西,宁夏,青海)
1419168828(北京,天津,河北,山东,陕西,辽宁,吉林,黑龙江)
3227045923(广东,福建,江西,四川,云南,贵州,广西,海南,澳门)